Hi guys, Welcome to the Advanced Video Search Engine, and you are watching Genetic mutations in ALL patients & implications for treatment decisions. That video is uploaded by VJHemOnc – Video Journal of Hematology & HemOnc at 2021-09-08T09:30:01-07:00. We are promoting this video only for entertainment and educational purpose only. So, I hope you like & enjoy it. [auib31HpMeY]
| Name | Genetic mutations in ALL patients & implications for treatment decisions |
| Video Uploader | Video From VJHemOnc – Video Journal of Hematology & HemOnc |
| Upload Date | This Video Uploaded At 08-09-2021 16:30:01 |
| Video Discription | Shawn Lee, MD, St. Jude Children's Research Hospital, Memphis, TN, discusses the genetic alterations found in patients with acute lymphoblastic leukaemia (ALL) and how impacts treatment decisions. Dr Lee describes the different genetic subtypes of ALL and the categorization of favorable, intermediate, and high-risk groups. Dr Lee also explains the prevalence of the different subgroups among different races and the treatment approaches used, before commenting on the importance of subtyping on treatment protocol design in different countries. This interview took place during the ninth annual meeting of the Society of Hematologic Oncology (SOHO 2021) congress. auib31HpMeY |
| Category | Education |
| Tags | Speaker: Shawn Lee | Institution: St. Jude Children's Research Hospital | Event: SOHO 2021 | Format: Interview | Subject: Acute Lymphoblastic Leukemia | Subject: Leukemia | Field: Disease Biology | Field: Treatment | Field: Clinical Practice | genetics | subtypes | categorization | treatment protocol designing | hyperdiploidy | black | asian | white | hispanic | african american | high-risk | intermediate | favourable | Philadelphia chromosome-positive | PH+ | BCR | ABL | T-ALL | T-cell ALL | tyrosine kinase inhibitors |
